The Zaleplon Market is gaining momentum as the global prevalence of sleep disorders such as insomnia continues to rise, prompting greater demand for clinically effective sedative-hypnotic medications. Zaleplon, a short-acting non-benzodiazepine hypnotic, is widely prescribed for individuals with difficulties initiating sleep due to its rapid onset of action and reduced likelihood of next-day...